● Tilg, H., & Moschen, A. R. (2010). "Evolution of inflammation in nonalcoholic fatty
liver disease: the multiple parallel hits hypothesis." Hepatology International ,
4(Suppl 1), S322–S330.
● Zhang, C., et al. (2019). "Omega-3 fatty acid supplementation improves
non-alcoholic fatty liver disease: a meta-analysis." Alimentary Pharmacology &
Therapeutics , 49(3), 251–262.
Citation Links
- Abdelmalek, M. F., et al. (2010). "Fructose consumption as a risk factor for
non-alcoholic fatty liver disease." Journal of Hepatology , 50(5), 937–943.
● DOI: 10.1016/j.jhep.2009.12.
- Abenavoli, L., et al. (2010). "Milk thistle in liver diseases: past, present, future."
Phytotherapy Research , 24(10), 1423–1432.
● DOI: 10.1002/ptr.
- Biddinger, S. B., & Kahn, C. R. (2006). "From mice to men: insights into the
insulin resistance syndromes." Journal of Clinical Investigation , 116(7),
1754–1760.
● DOI: 10.1172/JCI
- Grun, F., & Blumberg, B. (2009). "Endocrine disrupters as obesogens."
Environmental Health Perspectives , 117(6), A246–A253.
● DOI: 10.1289/ehp.
- Hursel, R., et al. (2009). "The effects of green tea on weight loss and weight
maintenance: a meta-analysis." International Journal of Obesity , 33(9), 956–961.
● DOI: 10.1038/ijo.2009.
- Kirk-Sanchez, N. J., & McGough, E. L. (2014). "Physical exercise and liver
disease." Hepatology International , 8(1), 152–161.
● DOI: 10.1007/s12072-013-9486-z
- Ma, Y., et al. (2018). "Dietary fiber intake is inversely associated with NAFLD in
adults." Nutrients , 10(10), 1362.
● DOI: 10.3390/nu
- Musso, G., et al. (2010). "Obesity, diabetes, lipid disturbances and NAFLD:
epidemiological, clinical and therapeutic considerations." American Journal of
Clinical Nutrition , 91(2), 434S–444S.
● DOI: 10.3945/ajcn.2009.28449B
- Panahi, Y., et al. (2016). "Curcuminoids modify lipid profile in NAFLD patients: a
randomized double-blind placebo-controlled trial." Nutrition , 32(2), 172–177.
● DOI: 10.1016/j.nut.2015.09.
